Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems
Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 1981-11, Vol.24 (11), p.1284-1287 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1287 |
---|---|
container_issue | 11 |
container_start_page | 1284 |
container_title | Journal of medicinal chemistry |
container_volume | 24 |
creator | Rogers, Michael E Glennon, Richard A Smith, J. Doyle Boots, Marvin R Nanavati, Nitin Maconaughey, Julie E Aub, Debbie Thomas, Sheree Bass, R. G Mbagwu, Godwin |
description | Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur atom of 1 or 2 with an N-methyl group nearly abolishes activity. Optimal activity appears to be associated with a hydrophobic substituent at the N8 position. The five-membered ring of 1 can be replaced by a pyridine or isoquinoline nucleus without untoward effects. Preliminary kinetic data suggest that the type of enzyme inhibition produced by the mesoionic derivatives is similar to that observed for theophylline. Thus, several novel mesoionic ring systems display activity as inhibitors of cyclic-AMP PDE and can serve as lead compounds for further investigation. |
doi_str_mv | 10.1021/jm00143a004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73756986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73756986</sourcerecordid><originalsourceid>FETCH-LOGICAL-a294t-2cc8e03d9d65eb8d4a1c4ff3b51fd8f853cc1437431f023e502baef72f3edb433</originalsourceid><addsrcrecordid>eNptkMtrGzEQxkVJSdykp54DOiWHsu3osQ_3FkJexW4Mds9Cq5USuburjcYb6v8-Mjahhx6Ggfl-fDPzEfKFwTcGnH1fdwBMCg0gP5AJyzlksgJ5RCYAnGe84OKEfEJcA4BgXByT44KXIs-rCWnnFoMPvTd0GKPvQ2-p7nUbnpBqpL5_9rXfhIg0OGq2pvUmu5ov6PAcMFXjLW5s1Gh_UBO6QUePod-xaF_TvKXJ84niNlEdnpGPTrdoPx_6Kfl9e7O6vs9mj3cP11ezTPOp3GTcmMqCaKZNkdu6aqRmRjon6py5pnJVLoxJ_5ZSMAdc2Bx4ra0ruRO2qaUQp-Ri7zvE8DKmC1Xn0di21b0NI6pSlHkxrYoEft2DJgbEaJ0aou903CoGapet-ifbRJ8fbMe6s807ewgz6dle9-nbv--yjn9UsVupVoul4nfL1c_7XzM1T_zlntcG1TqMMeWO_938BijwkkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73756986</pqid></control><display><type>article</type><title>Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Rogers, Michael E ; Glennon, Richard A ; Smith, J. Doyle ; Boots, Marvin R ; Nanavati, Nitin ; Maconaughey, Julie E ; Aub, Debbie ; Thomas, Sheree ; Bass, R. G ; Mbagwu, Godwin</creator><creatorcontrib>Rogers, Michael E ; Glennon, Richard A ; Smith, J. Doyle ; Boots, Marvin R ; Nanavati, Nitin ; Maconaughey, Julie E ; Aub, Debbie ; Thomas, Sheree ; Bass, R. G ; Mbagwu, Godwin</creatorcontrib><description>Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur atom of 1 or 2 with an N-methyl group nearly abolishes activity. Optimal activity appears to be associated with a hydrophobic substituent at the N8 position. The five-membered ring of 1 can be replaced by a pyridine or isoquinoline nucleus without untoward effects. Preliminary kinetic data suggest that the type of enzyme inhibition produced by the mesoionic derivatives is similar to that observed for theophylline. Thus, several novel mesoionic ring systems display activity as inhibitors of cyclic-AMP PDE and can serve as lead compounds for further investigation.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00143a004</identifier><identifier>PMID: 6273558</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>3',5'-Cyclic-AMP Phosphodiesterases - antagonists & inhibitors ; Chemical Phenomena ; Chemistry ; Purinones - chemical synthesis ; Purinones - pharmacology</subject><ispartof>Journal of medicinal chemistry, 1981-11, Vol.24 (11), p.1284-1287</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a294t-2cc8e03d9d65eb8d4a1c4ff3b51fd8f853cc1437431f023e502baef72f3edb433</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00143a004$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00143a004$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6273558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rogers, Michael E</creatorcontrib><creatorcontrib>Glennon, Richard A</creatorcontrib><creatorcontrib>Smith, J. Doyle</creatorcontrib><creatorcontrib>Boots, Marvin R</creatorcontrib><creatorcontrib>Nanavati, Nitin</creatorcontrib><creatorcontrib>Maconaughey, Julie E</creatorcontrib><creatorcontrib>Aub, Debbie</creatorcontrib><creatorcontrib>Thomas, Sheree</creatorcontrib><creatorcontrib>Bass, R. G</creatorcontrib><creatorcontrib>Mbagwu, Godwin</creatorcontrib><title>Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur atom of 1 or 2 with an N-methyl group nearly abolishes activity. Optimal activity appears to be associated with a hydrophobic substituent at the N8 position. The five-membered ring of 1 can be replaced by a pyridine or isoquinoline nucleus without untoward effects. Preliminary kinetic data suggest that the type of enzyme inhibition produced by the mesoionic derivatives is similar to that observed for theophylline. Thus, several novel mesoionic ring systems display activity as inhibitors of cyclic-AMP PDE and can serve as lead compounds for further investigation.</description><subject>3',5'-Cyclic-AMP Phosphodiesterases - antagonists & inhibitors</subject><subject>Chemical Phenomena</subject><subject>Chemistry</subject><subject>Purinones - chemical synthesis</subject><subject>Purinones - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkMtrGzEQxkVJSdykp54DOiWHsu3osQ_3FkJexW4Mds9Cq5USuburjcYb6v8-Mjahhx6Ggfl-fDPzEfKFwTcGnH1fdwBMCg0gP5AJyzlksgJ5RCYAnGe84OKEfEJcA4BgXByT44KXIs-rCWnnFoMPvTd0GKPvQ2-p7nUbnpBqpL5_9rXfhIg0OGq2pvUmu5ov6PAcMFXjLW5s1Gh_UBO6QUePod-xaF_TvKXJ84niNlEdnpGPTrdoPx_6Kfl9e7O6vs9mj3cP11ezTPOp3GTcmMqCaKZNkdu6aqRmRjon6py5pnJVLoxJ_5ZSMAdc2Bx4ra0ruRO2qaUQp-Ri7zvE8DKmC1Xn0di21b0NI6pSlHkxrYoEft2DJgbEaJ0aou903CoGapet-ifbRJ8fbMe6s807ewgz6dle9-nbv--yjn9UsVupVoul4nfL1c_7XzM1T_zlntcG1TqMMeWO_938BijwkkA</recordid><startdate>198111</startdate><enddate>198111</enddate><creator>Rogers, Michael E</creator><creator>Glennon, Richard A</creator><creator>Smith, J. Doyle</creator><creator>Boots, Marvin R</creator><creator>Nanavati, Nitin</creator><creator>Maconaughey, Julie E</creator><creator>Aub, Debbie</creator><creator>Thomas, Sheree</creator><creator>Bass, R. G</creator><creator>Mbagwu, Godwin</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198111</creationdate><title>Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems</title><author>Rogers, Michael E ; Glennon, Richard A ; Smith, J. Doyle ; Boots, Marvin R ; Nanavati, Nitin ; Maconaughey, Julie E ; Aub, Debbie ; Thomas, Sheree ; Bass, R. G ; Mbagwu, Godwin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a294t-2cc8e03d9d65eb8d4a1c4ff3b51fd8f853cc1437431f023e502baef72f3edb433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>3',5'-Cyclic-AMP Phosphodiesterases - antagonists & inhibitors</topic><topic>Chemical Phenomena</topic><topic>Chemistry</topic><topic>Purinones - chemical synthesis</topic><topic>Purinones - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rogers, Michael E</creatorcontrib><creatorcontrib>Glennon, Richard A</creatorcontrib><creatorcontrib>Smith, J. Doyle</creatorcontrib><creatorcontrib>Boots, Marvin R</creatorcontrib><creatorcontrib>Nanavati, Nitin</creatorcontrib><creatorcontrib>Maconaughey, Julie E</creatorcontrib><creatorcontrib>Aub, Debbie</creatorcontrib><creatorcontrib>Thomas, Sheree</creatorcontrib><creatorcontrib>Bass, R. G</creatorcontrib><creatorcontrib>Mbagwu, Godwin</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rogers, Michael E</au><au>Glennon, Richard A</au><au>Smith, J. Doyle</au><au>Boots, Marvin R</au><au>Nanavati, Nitin</au><au>Maconaughey, Julie E</au><au>Aub, Debbie</au><au>Thomas, Sheree</au><au>Bass, R. G</au><au>Mbagwu, Godwin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1981-11</date><risdate>1981</risdate><volume>24</volume><issue>11</issue><spage>1284</spage><epage>1287</epage><pages>1284-1287</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur atom of 1 or 2 with an N-methyl group nearly abolishes activity. Optimal activity appears to be associated with a hydrophobic substituent at the N8 position. The five-membered ring of 1 can be replaced by a pyridine or isoquinoline nucleus without untoward effects. Preliminary kinetic data suggest that the type of enzyme inhibition produced by the mesoionic derivatives is similar to that observed for theophylline. Thus, several novel mesoionic ring systems display activity as inhibitors of cyclic-AMP PDE and can serve as lead compounds for further investigation.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>6273558</pmid><doi>10.1021/jm00143a004</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1981-11, Vol.24 (11), p.1284-1287 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_73756986 |
source | MEDLINE; American Chemical Society Journals |
subjects | 3',5'-Cyclic-AMP Phosphodiesterases - antagonists & inhibitors Chemical Phenomena Chemistry Purinones - chemical synthesis Purinones - pharmacology |
title | Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T08%3A53%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mesoionic%20purinone%20analogs%20as%20inhibitors%20of%20cyclic-AMP%20phosphodiesterase:%20comparison%20of%20several%20ring%20systems&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Rogers,%20Michael%20E&rft.date=1981-11&rft.volume=24&rft.issue=11&rft.spage=1284&rft.epage=1287&rft.pages=1284-1287&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm00143a004&rft_dat=%3Cproquest_cross%3E73756986%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73756986&rft_id=info:pmid/6273558&rfr_iscdi=true |